Anondita Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.81 Cr
as on 24-10-2024
- Satisfied Charges ₹ 9.01 Cr
as on 24-10-2024
- Revenue -61.93%
(FY 2023)
- Profit -116.51%
(FY 2023)
- Ebitda -10.74%
(FY 2023)
- Net Worth -9.67%
(FY 2023)
- Total Assets 27.98%
(FY 2023)
About Anondita Healthcare Products
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹26.81 Cr. The company has closed loans amounting to ₹9.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anupam Ghosh and Sonia Ghosh serve as directors at the Company.
- CIN/LLPIN
U85100DL2014PTC274717
- Company No.
274717
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Anondita Healthcare Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupam Ghosh  | Director | 29-Dec-2014 | Current |
| Sonia Ghosh | Director | 29-Dec-2014 | Current |
Financial of Anondita Healthcare Products.
Anondita Healthcare Products Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 61.93% decrease. The company also saw a substantial fall in profitability, with a 116.51% decrease in profit. The company's net worth dipped by a decrease of 9.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anondita Healthcare Products?
In 2023, Anondita Healthcare Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anondita Healthcare Private LimitedActive 15 years 3 monthsAnupam Ghosh and Sonia Ghosh are mutual person
- Anondita Latex Products (India) Private LimitedActive 10 years 8 months
Anupam Ghosh and Sonia Ghosh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Oct 2021 | ₹1.68 Cr | Open |
Others Creation Date: 30 Sep 2021 | ₹3.20 M | Open |
Others Creation Date: 30 Sep 2021 | ₹16.57 Cr | Open |
How Many Employees Work at Anondita Healthcare Products?
Anondita Healthcare Products has a workforce of 3 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anondita Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anondita Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
